It was showed that the level and frequency of anti-ENO1 in sera from patients with NSCLC are significantly higher than that in sera from normal individuals, and detection of anti-ENO1 could differentiate NSCLC from normal individuals with AUC (95%CI) of 0.589 (0.539-0.638). This evidence concerns the gene ENO1 and non-small cell lung carcinoma.